indirubin-3'-monoxime and troglitazone

indirubin-3'-monoxime has been researched along with troglitazone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Boyce, RS; Brown, SP; Bussiere, DE; Fang, E; Goff, D; Harrison, SD; Jansen, JM; Johnson, KW; Le, VP; Levine, BH; Ng, SC; Ni, ZJ; Nuss, JM; Pfister, KB; Ramurthy, S; Renhowe, PA; Ring, DB; Shafer, CM; Shu, W; Subramanian, S; Wagman, AS; Zhou, XA1

Other Studies

2 other study(ies) available for indirubin-3'-monoxime and troglitazone

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3.
    Journal of medicinal chemistry, 2017, 10-26, Volume: 60, Issue:20

    Topics: Animals; CHO Cells; Chromatography, High Pressure Liquid; Cricetulus; Crystallography, X-Ray; Enzyme Inhibitors; Glycogen Synthase Kinases; Humans; Hypoglycemic Agents; Mass Spectrometry; Proton Magnetic Resonance Spectroscopy; Pyrimidines; Rats; Structure-Activity Relationship

2017